查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1378837

2023-2028 年內分泌檢測市場報告（按檢測類型、技術、最終用途和地區）

Endocrine Testing Market Report by Test Type, Technology, End Use, and Region 2023-2028
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

概要

2022年，全球內分泌檢測市場規模達到104億美元。展望未來， IMARC Group預計到2028年市場規模將達到164億美元，2022-2028年複合年成長率（CAGR）為7.9%。

內分泌檢測是指為測量體內荷爾蒙水平和診斷荷爾蒙相關疾病而進行的醫療程序。此測試有助於檢測可能導致某些慢性病發展的荷爾蒙濃度不平衡。這些疾病通常透過細針抽吸 (FNA)、超音波、電腦斷層掃描 (CT)、磁振造影 (MRI)、正子發射測試 (PET)、放射性碘掃描 (RAI) 和靜脈採樣進行測試。由此獲得的測試結果可以幫助確定疾病的進展並監測向患者提供的治療的效果

腎上腺功能不全、庫欣氏症、巨人症、甲狀腺功能低下症和甲狀腺功能亢進等內分泌相關疾病的盛行率日益增加，是推動市場成長的關鍵因素之一。此外，健康意識的增強以及對及時檢測益處的認知的增強也推動了市場的成長。定期檢測可以最大限度地降低併發症或病情惡化的風險，尤其是老年患者。與此一致的是，不斷成長的老年人口正在成為另一個主要的成長誘導因素。此外，由於冠狀病毒（COVID-19）大流行的爆發，內分泌檢測被廣泛用於檢測感染患者的高血糖情況。此外，配備生物感測器的易於操作的創新測試套件的開發，有助於方便用戶使用且經濟高效的家庭診斷，正在為市場創造積極的前景。醫療保健中心、實驗室和診斷中心還使用技術先進的液相層析和質譜 (LC-MS) 技術來提供高度精確和準確的結果。其他因素，包括醫療保健基礎設施的改善，預計將進一步推動市場。

本報告回答的關鍵問題：

  • 迄今為止，全球內分泌檢測市場表現如何，未來幾年將如何表現？
  • COVID-19 對全球內分泌檢測市場有何影響？
  • 主要區域市場有哪些？
  • 根據測試類型，市場的細分是什麼？
  • 基於技術的市場區隔是什麼？
  • 根據最終用途分類的市場是怎樣的？
  • 產業價值鏈的各個階段是什麼？
  • 該行業的關鍵促進因素和挑戰是什麼？
  • 全球內分泌檢測市場的結構如何？誰是主要參與者？
  • 產業競爭程度如何？

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球內分泌檢測市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：按測試類型分類的市場

  • 甲狀腺檢查
    • 市場走向
    • 市場預測
  • 胰島素測試
    • 市場走向
    • 市場預測
  • 人類絨毛膜促性腺激素測試
    • 市場走向
    • 市場預測
  • 催乳素測試
    • 市場走向
    • 市場預測
  • 黃體生成素測試
    • 市場走向
    • 市場預測
  • 黃體酮測試
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章：依科技分類的市場

  • 免疫分析
    • 市場走向
    • 市場預測
  • 串聯質譜
    • 市場走向
    • 市場預測
  • 感測器技術
    • 市場走向
    • 市場預測
  • 液態聯用
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：依最終用途分類的市場區隔

  • 醫院
    • 市場走向
    • 市場預測
  • 門診護理中心
    • 市場走向
    • 市場預測
  • 臨床實驗室
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章：按地區分類的市場區隔

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太地區
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 按國家/地區分類的市場細分
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • Agilent Technologies Inc.
    • Bio-Rad Laboratories Inc.
    • BioMerieux SA
    • DiaSorin SpA
    • F. Hoffmann-La Roche AG (Roche Holding AG)
    • Laboratory Corporation of America Holdings
    • Quest Diagnostics Incorporated
    • Siemens Healthineers AG (Siemens Aktiengesellschaft)
    • Thermo Fisher Scientific Inc.
Product Code: SR112023A2900

Abstract

The global endocrine testing market size reached US$ 10.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 16.4 Billion by 2028, exhibiting a growth rate (CAGR) of 7.9% during 2022-2028.

Endocrine testing refers to the medical procedures conducted to measure the hormonal levels in the body and the diagnosis of hormone-related disorders. The testing aids in detecting an imbalance in the concentrations of hormones that may lead to the development of certain chronic conditions. These disorders are usually tested by fine-needle aspiration (FNA), ultrasound, computerized tomography (CT), magnetic resonance imaging (MRI), positron emission test (PET), radioactive iodine scan (RAI) and venous sampling. The test results thus obtained can assist in determining the progression of the disorder and monitoring the effects of the treatment being provided to the patient

The increasing prevalence of endocrine-related disorders, such as adrenal insufficiency, Cushing's disease, gigantism, hypothyroidism and hyperthyroidism, represents one of the key factors driving the growth of the market. Furthermore, the increasing health consciousness and awareness regarding the benefits of timely testing is providing a boost to the market growth. Periodic testing minimizes the risks of developing complications or aggravation of the disorder, especially in elderly patients. In line with this, the rising geriatric population is acting as another major growth-inducing factor. Moreover, due to the onset of the coronavirus (COVID-19) pandemic, endocrine testing is being widely used to detect hyperglycemia in infected patients. Additionally, the development of innovative easy-to-operate test kits equipped with biosensors that facilitate user-friendly and cost-effective home-based diagnosis is creating a positive outlook for the market. Healthcare centers, laboratories and diagnostic centers are also using technologically advanced liquid chromatography with mass spectrometry (LC-MS) techniques to provide highly precise and accurate results. Other factors, including improvements in the healthcare infrastructure, are anticipated to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global endocrine testing market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on test type, technology and end use.

Breakup by Test Type:

Thyroid Test

Insulin Test

Human Chorionic Gonadotropin Test

Prolactin Test

Luteinizing Hormone Test

Progesterone Test

Others

Breakup by Technology:

Immunoassay

Tandem Mass Spectroscopy

Sensor Technology

LC-MS

Others

Breakup by End Use:

Hospitals

Ambulatory Care Centers

Clinical Laboratories

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., BioMerieux SA, DiaSorin S.p.A., F. Hoffmann-La Roche AG (Roche Holding AG), Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Siemens Healthineers AG (Siemens Aktiengesellschaft) and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global endocrine testing market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global endocrine testing market?
  • What are the key regional markets?
  • What is the breakup of the market based on the test type?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the end use?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global endocrine testing market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Endocrine Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Test Type

  • 6.1 Thyroid Test
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Insulin Test
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Human Chorionic Gonadotropin Test
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Prolactin Test
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Luteinizing Hormone Test
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Progesterone Test
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Others
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Immunoassay
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Tandem Mass Spectroscopy
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Sensor Technology
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 LC-MS
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End Use

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Care Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Clinical Laboratories
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Agilent Technologies Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Bio-Rad Laboratories Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 BioMerieux SA
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 DiaSorin S.p.A.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 F. Hoffmann-La Roche AG (Roche Holding AG)
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 SWOT Analysis
    • 14.3.7 Laboratory Corporation of America Holdings
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Quest Diagnostics Incorporated
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Siemens Healthineers AG (Siemens Aktiengesellschaft)
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Thermo Fisher Scientific Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Endocrine Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Endocrine Testing Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Endocrine Testing Market: Breakup by Test Type (in %), 2022
  • Figure 4: Global: Endocrine Testing Market: Breakup by Technology (in %), 2022
  • Figure 5: Global: Endocrine Testing Market: Breakup by End Use (in %), 2022
  • Figure 6: Global: Endocrine Testing Market: Breakup by Region (in %), 2022
  • Figure 7: Global: Endocrine Testing Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 8: Global: Endocrine Testing (Thyroid Test) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Endocrine Testing (Thyroid Test) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Endocrine Testing (Insulin Test) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Endocrine Testing (Insulin Test) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Endocrine Testing (Human Chorionic Gonadotropin Test) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Endocrine Testing (Human Chorionic Gonadotropin Test) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Endocrine Testing (Prolactin Test) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Endocrine Testing (Prolactin Test) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Endocrine Testing (Luteinizing Hormone Test) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Endocrine Testing (Luteinizing Hormone Test) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Endocrine Testing (Progesterone Test) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Endocrine Testing (Progesterone Test) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Endocrine Testing (Other Test Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Endocrine Testing (Other Test Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Endocrine Testing (Immunoassay) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Endocrine Testing (Immunoassay) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Endocrine Testing (Tandem Mass Spectroscopy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Endocrine Testing (Tandem Mass Spectroscopy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Endocrine Testing (Sensor Technology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Endocrine Testing (Sensor Technology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Endocrine Testing (LC-MS) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Endocrine Testing (LC-MS) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Endocrine Testing (Other Technologies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Endocrine Testing (Other Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Global: Endocrine Testing (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Global: Endocrine Testing (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Global: Endocrine Testing (Ambulatory Care Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Global: Endocrine Testing (Ambulatory Care Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Global: Endocrine Testing (Clinical Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Global: Endocrine Testing (Clinical Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Global: Endocrine Testing (Other End Uses) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Global: Endocrine Testing (Other End Uses) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: North America: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: North America: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: United States: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: United States: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Canada: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Canada: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Asia Pacific: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Asia Pacific: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: China: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: China: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Japan: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Japan: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: India: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: India: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: South Korea: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: South Korea: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Australia: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Australia: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Indonesia: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Indonesia: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Others: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Others: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Europe: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Europe: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Germany: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Germany: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: France: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: France: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: United Kingdom: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: United Kingdom: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Italy: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Italy: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Spain: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Spain: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Russia: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Russia: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Others: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Others: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Latin America: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Latin America: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Brazil: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 81: Brazil: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Mexico: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 83: Mexico: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 84: Others: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 85: Others: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 86: Middle East and Africa: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 87: Middle East and Africa: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 88: Global: Endocrine Testing Industry: SWOT Analysis
  • Figure 89: Global: Endocrine Testing Industry: Value Chain Analysis
  • Figure 90: Global: Endocrine Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Endocrine Testing Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Endocrine Testing Market Forecast: Breakup by Test Type (in Million US$), 2023-2028
  • Table 3: Global: Endocrine Testing Market Forecast: Breakup by Technology (in Million US$), 2023-2028
  • Table 4: Global: Endocrine Testing Market Forecast: Breakup by End Use (in Million US$), 2023-2028
  • Table 5: Global: Endocrine Testing Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Endocrine Testing Market Structure
  • Table 7: Global: Endocrine Testing Market: Key Players